MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
181.87%
Quick Ratio
181.87%
Cash Ratio
143.64%
Debt to Asset Ratio
72.05%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Restricted cash
    • Advances and deposits on clinica...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Note payable-Related Party B
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
6,864,378
8,781,059
5,250,929
4,728,776
Advances and deposits on clinical programs and other current assets
1,826,825
1,942,685
2,006,756
2,162,469
Total current assets
8,691,203
10,723,744
7,257,685
6,891,245
Property and equipment gross
-
1,805,877
-
-
Less accumulated depreciation and amortization
-
1,275,941
-
-
Property and equipment (at cost, less accumulated depreciation and amortization)
459,016
529,936
601,425
676,565
Restricted cash
5,000,000
-
-
-
Operating lease right-of-use assets, net
788,894
984,436
1,078,623
1,170,517
Deposits and other assets
50,000
50,000
50,000
50,000
Total other assets
5,838,894
1,034,436
1,128,623
1,220,517
Total assets
14,989,113
12,288,116
8,987,733
8,788,327
Accounts payable trade
1,618,497
1,392,829
1,126,826
1,735,568
Other accrued liabilities
1,228,568
2,824,646
2,676,951
3,199,502
Note payable - note a current portion
1,500,000
-
-
-
Operating lease liability - current portion
431,781
406,354
394,135
382,217
Total current liabilities
4,778,846
4,623,829
4,197,912
5,317,287
Note payable-Related Party A
673,271
-
-
-
Note payable-Related Party B
4,860,831
-
-
-
Operating lease liability - non-current portion
379,409
602,411
708,097
811,190
Derivative liability associated with redemption feature of note a
107,969
-
-
-
Total liabilities
10,800,326
5,226,240
4,906,009
6,128,477
Preferred stock - 0.01 par value (100,000 shares authorized 250 shares issued and outstanding at june 30, 2026, and no shares issued or outstanding at december 31, 2025)
3
-
-
-
Additional paid-in capital - preferred stock
2,251,918
-
-
-
Common stock - 0.01 par value (350,000,000 shares authorized 4,665,662 and 3,419,652 shares issued at june 30, 2026 and december 31, 2025, respectively and 4,665,660 and 3,419,650 shares outstanding at june 30, 2026 and december 31, 2025, respectively)
46,657
34,197
28,963
17,175
Additional paid-in capital
430,336,605
428,410,939
421,213,171
416,373,961
Accumulated deficit
-428,361,208
-421,298,072
-417,075,222
-413,646,098
Total stockholders equity before treasury stock
4,273,975
7,147,064
4,166,912
2,745,038
Treasury stock, at cost (2 shares at june 30, 2026 and december 31, 2025)
85,188
85,188
85,188
85,188
Total stockholders equity
4,188,787
7,061,876
4,081,724
2,659,850
Total liabilities and stockholders equity
14,989,113
12,288,116
8,987,733
8,788,327
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$6,864,378 (45.16%↑ Y/Y)Advances and deposits onclinical programs and...$1,826,825 (-15.52%↓ Y/Y)Restricted cash$5,000,000 Operating leaseright-of-use assets, net$788,894 (-32.60%↓ Y/Y)Deposits and other assets$50,000 (0.00%↑ Y/Y)Total current assets$8,691,203 (26.12%↑ Y/Y)Total other assets$5,838,894 (378.40%↑ Y/Y)Property and equipment(at cost, less...$459,016 (-32.15%↓ Y/Y)Total assets$14,989,113 (70.56%↑ Y/Y)Total liabilities andstockholders equity$14,989,113 (70.56%↑ Y/Y)Total liabilities$10,800,326 (76.23%↑ Y/Y)Total stockholdersequity$4,188,787 (57.48%↑ Y/Y)Treasury stock, at cost (2shares at june 30, 2026...$85,188 (0.00%↑ Y/Y)Notepayable-Related Party B$4,860,831 Total currentliabilities$4,778,846 (-10.13%↓ Y/Y)Notepayable-Related Party A$673,271 Operating lease liability- non-current...$379,409 (-53.23%↓ Y/Y)Derivative liabilityassociated with redemption...$107,969 Total stockholdersequity before treasury...$4,273,975 (55.70%↑ Y/Y)Accumulated deficit-$428,361,208 (-3.56%↓ Y/Y)Accounts payable trade$1,618,497 (-6.75%↓ Y/Y)Note payable - note a current portion$1,500,000 Other accruedliabilities$1,228,568 (-61.60%↓ Y/Y)Operating lease liability- current portion$431,781 (12.97%↑ Y/Y)Additional paid-in capital$430,336,605 (3.35%↑ Y/Y)Additional paid-in capital- preferred stock$2,251,918 Common stock - 0.01 parvalue (350,000,000...$46,657 (171.66%↑ Y/Y)Preferred stock - 0.01 parvalue (100,000 shares...$3

Imunon, Inc. (IMNN)

Imunon, Inc. (IMNN)